Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,043 | -30,948 | -15,005 | -7,985 | -8,399 |
| Depreciation Amortization | 10 | 24 | 14 | 11 | 5 |
| Accounts receivable | N/A | N/A | N/A | -10,000 | N/A |
| Accounts payable and accrued liabilities | 668 | -75 | 1,374 | -989 | 728 |
| Other Working Capital | -8,799 | 10,700 | 1,190 | -13,898 | -4,473 |
| Other Operating Activity | 47 | 2,211 | 235 | 12,069 | -205 |
| Operating Cash Flow | $-16,118 | $-18,088 | $-12,192 | $-20,792 | $-12,344 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -63 | -60 | -5 | -5 |
| Investing Cash Flow | $N/A | $-63 | $-60 | $-5 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,299 | 1,343 | 1,343 | 1,339 | N/A |
| Financing Cash Flow | $1,299 | $1,343 | $1,343 | $1,339 | $0 |
| Exchange Rate Effect | -22 | -196 | -376 | -145 | -9 |
| Beginning Cash Position | 34,670 | 51,674 | 51,674 | 51,674 | 51,674 |
| End Cash Position | 19,829 | 34,670 | 40,390 | 32,071 | 39,317 |
| Net Cash Flow | $-14,840 | $-17,005 | $-11,285 | $-19,604 | $-12,357 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,118 | -18,088 | -12,192 | -20,792 | -12,344 |
| Capital Expenditure | N/A | -63 | -60 | -5 | -5 |
| Free Cash Flow | -16,118 | -18,152 | -12,252 | -20,797 | -12,348 |